Predictive value of the asymptomatic prostatic inflammation in the development of prostate cancer;Valeur prédictive de l'inflammation prostatiqueasymptomatique dans la survenue du cancerde la prostate

Progres en Urologie

Volumn 20, Issue 7, 2010, Pages 508-514

  Molimard, B ^a   Camparo, P ^a   Desfemmes, F R ^a   Durand, X ^a   Haus, R ^b   Deligne, E ^a   Houlgatte, A ^a   Comperat E ^c  

^a University of Paris Descartes   (France)

^b Ecole du Val de Grace   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Asymptomatic; Biopsy; High grade PIN; Inflammation; PIA; Prostate cancer; Prostate specific antigen

Indexed keywords

AGED; ARTICLE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; PROSTATITIS; RETROSPECTIVE STUDY;

AGED; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; PROSTATITIS; RETROSPECTIVE STUDIES;

EID: 77955054381     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2010.01.001     Document Type: Article

References (20)

1. CCAFU. Recommandations 2007 en onco-urologie. Prog Urol 2007;17:1013-230.
2. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
3. De Marzo A.M., Marchi V.L., Epstein J.I., Nelson W.G. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999, 155:1985-1992.
4. De Marzo A.M., Platz E.A., Sutcliffe S., Xu J., Gronberg H., Drake C.G., et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007, 7:256-269.
5. Dennis L.K., Dawson D.V. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 2002, 13:72-79.
6. Roberts R.O., Bergstralh E.J., Bass S.E., Lieber M.M., Jacobsen S.J. Prostatitis as a risk factor for prostate cancer. Epidemiology 2004, 15:93-99.
7. Palapattu G.S., Sutcliffe S., Bastian P.J., Platz E.A., de Marzo A.M., Isaacs W.B., et al. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005, 26:1170-1181.
8. Sciarra A., Di Silverio F., Salciccia S., Autran Gomez A.M., Gentilucci A., Gentile V. Inflammation and chronic prostatic diseases: evidence for a link?. Eur Urol 2007, 52:964-972.
9. Carver B.S., Bozeman C.B., Williams B.J., Venable D.D. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol 2003, 169:589-591.
10. Nickel J.C., True L.D., Krieger J.N., Berger R.E., Boag A.H., Young I.D. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001, 87:797-805.
11. Karakiewicz P.I., Benayoun S., Begin L.R., Duclos A., Valiquette L., McCormack M., et al. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intra-epithelial neoplasia on needle biopsy. Int J Clin Pract 2007, 61:425-430.
12. Wolters T., Roobol M.J., Schroder F.H., van der Kwast T.H., Roemeling S., van der Cruijsen-Koeter I.W., et al. Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at rescreening after 4 years?. BJU Int 2008, 101:283-288.
13. MacLennan G.T., Eisenberg R., Fleshman R.L., Taylor J.M., Fu P., Resnick M.I., et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol 2006, 176:1012-1016.
14. Fournier G., Valeri A., Mangin P., Cussenot O. Cancer de la prostate, épidémiologie, facteurs de risques, anatomopathologie. Ann Urol (Paris) 2004, 38:187-206.
15. Neal D.E., Clejan S., Sarma D., Moon T.D. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and non-human primate. Prostate 1992, 20:105-111.
16. Morote J., Lopez M., Encabo G., de Torres I.M. Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 2000, 37:537-540.
17. Singh H., Canto E.I., Shariat S.F., Kadmon D., Miles B.J., Wheeler T.M., et al. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol 2004, 171:1850-1854.
18. Epstein J.I., Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 2006, 175:820-834.
19. Postma R., Roobol M., Schroder F.H., van der Kwast T.H. Lesions predictive for prostate cancer in a screened population: first and second screening round findings. Prostate 2004, 61:260-266.
20. Postma R., Schroder F.H., van der Kwast T.H. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 2005, 65:745-749.